跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Ceftazidime for Injection
Approved
化学药品
Ceftazidime for Injection
Hanmi Pharm. Co., Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Mar 26, 2020
Approval ID
7LeagVbEjqe
Company
Hanmi Pharm. Co., Ltd.
Type
化学药品
Approval Details
Approval Id
7LeagVbEjqe
Approval Number
国药准字J20160030
Generic Name
注射用头孢他啶
Generic Name En
Ceftazidime for Injection
Trade Name
泰得欣
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.0g(按C22H22N6O7S2计)
Reg Date
2020-03-26
Company Name
Hanmi Pharm. Co., Ltd.
Company Address
214, Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do, Korea
Production Company Name
Hanmi Pharm. Co., Ltd.
Production Company Address
114,Chupalsandan-ro,Paengseong-eup,Pyeongtaek-si,Gyeonggi-do,Korea
Company Detail Path
/organization/hanmi-pharm-co-ltd
Production Company Detail Path
/organization/hanmi-pharm-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 26, 2020
Approval ID
7LeagVbEjqe
Type
化学药品
Back to NMPA Approvals
泰得欣 - NMPA Drug Approval Details